Company / R&D per Share
Jade Biosciences, Inc. R&D per Share History
FY2020-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.86
FY2024
5-year range
$1.22 / $32.78
FY2020-FY2024
Trend
-23.7%
vs FY2023
Sector context
#102 of 204
Health Care
What the data says
At $1.86, Jade Biosciences, Inc.'s r&d per share ranks #102 of 204 in the Health Care sector. Improved from $1.58 to $1.86 over the past 2 years.
Based on SEC 10-K filings.
1.86 in FY2024 with a 3-year CAGR of +15.1%.
Improved from $1.58 to $1.86 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +15.1%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
#102 of 204 in Health CareTop 50% of 204This company $1.86 Sector average $34.99
▼
-94.7% below sector average
Key checks
Key Insights
- In FY2024, r&d per share decreased 23.7% year-over-year.
- Ranks #102 out of 204 companies in the Health Care sector.
- Peak r&d per share was recorded in FY2020.
- Lowest r&d per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 6.03 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $1.86 | -23.7% |
| FY2023 | $2.44 | +54.5% |
| FY2022 | $1.58 | +29.5% |
| FY2021 | $1.22 | -96.3% |
| FY2020 | $32.78 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026